Acute inferior myocardial infarction associated with the ingestion of captagon pills: A case report

Mehmet Tahir Gokdemir; Ramazan Giden

doi:10.1016/j.tjem.2018.05.001

Mehmet Tahir Gokdemir¹, Ramazan Giden²

¹Health Sciences University, Gazi Yasargil Research and Training Hospital, Emergency Medicine Department, Diyarbakır, Turkey
²Sanliurfa Research and Training Hospital, Emergency Department, Sanliurfa, Turkey

Keywords: Phenylethylamine(captagon), Acute inferior myocardial infarction, Emergency department

Abstract

Phenylethylamine HCL (PEA HCL), more commonly called Captagon on the market, is a synthetic stimulant consisting of a theophylline molecule covalently bonded to an amphetamine molecule. The pathophysiology of myocardial infarction (MI) causing amphetamine-like compounds such as amphetamine and phenylethyline is not clear, this effect may be attributed to the vessel wall narrowing and destabilization of the thrombus. In the literature, some cases of acute myocardial infarction (AMI) associated with amphetamine and ephedrine abuse already been reported. To our knowledge, there is only a cases reporting AMI associated with the use of PEA commonly called Captagon. In this case, we wanted to contribute to the literature by presenting the case of a 23-year-old who developed PEA due to captagon tablet use.